Emerging Therapeutic Options for the Management of COPD

被引：10
|
作者：
Reid, Debra J. [1 ]
Pham, Nga T. [1 ]
机构：
[1] Northeastern Univ, Sch Pharm, Dept Pharm Practice, Boston, MA 02115 USA
来源：
CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE | 2013年 / 7卷
关键词：
chronic obstructive pulmonary disease; COPD therapy; long-acting muscarinic agent; phosphodiesterase-4; inhibitor; long-acting beta(2)-agonist;
D O I：
10.4137/CCRPM.S8140
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.
引用
收藏
页码：7 / 15
页数：9
相关论文
共 50 条
  • [21] EMERGING THERAPEUTIC OPTIONS AGAINST FILOVIRUSES
    Reid, St. P.
    Shurtleff, A. C.
    Bavari, S.
    DRUGS OF THE FUTURE, 2012, 37 (05) : 343 - 351
  • [22] Emerging therapeutic options for refractory gout
    Jatuworapruk, Kanon
    Louthrenoo, Worawit
    NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (02) : 73 - 74
  • [23] Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options
    Lewis, Russell
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 645 - 657
  • [24] Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions
    Ansari, Mohammad Azam
    Chauhan, Waseem
    Shoaib, Shoaib
    Alyahya, Sami A.
    Ali, Mubashshir
    Ashraf, Hamid
    Alomary, Mohammad N.
    Al-Suhaimi, Ebtesam A.
    INTERNATIONAL JOURNAL OF OBESITY, 2023, 47 (12) : 1179 - 1199
  • [25] Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions
    Mohammad Azam Ansari
    Waseem Chauhan
    Shoaib Shoaib
    Sami A. Alyahya
    Mubashshir Ali
    Hamid Ashraf
    Mohammad N. Alomary
    Ebtesam A. Al-Suhaimi
    International Journal of Obesity, 2023, 47 : 1179 - 1199
  • [26] Recurrent pericarditis: new and emerging therapeutic options
    Massimo Imazio
    George Lazaros
    Antonio Brucato
    Fiorenzo Gaita
    Nature Reviews Cardiology, 2016, 13 : 99 - 105
  • [27] Emerging Therapeutic Options in Acute Lymphoblastic Leukemia
    Brown, Patrick A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (12): : 1781 - 1784
  • [28] Therapeutic options for mucopolysaccharidoses: Current and emerging treatments
    Tomatsu, Shunji
    Sawamoto, Kazuki
    Stapleton, Molly
    Almeciga-Diaz, Carlos J.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S154 - S154
  • [29] New and Emerging Therapeutic Options for Thyroid Carcinoma
    Shah, Jatin P.
    Clayman, Gary L.
    Wirth, Lori J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (04) : 1 - 2
  • [30] Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
    Sawamoto, Kazuki
    Stapleton, Molly
    Almeciga-Diaz, Carlos J.
    Espejo-Mojica, Angela J.
    Camilo Losada, Juan
    Suarez, Diego A.
    Tomatsu, Shunji
    DRUGS, 2019, 79 (10) : 1103 - 1134
12345